[en] To assess the variation of thrombopoietin (TPO) responsiveness associated with megakaryocyte (MK) progenitor amplification, TPO dose-response curves were obtained for normal human, single-cell plated CD34(+)CD41(+) cells. The number of MKs per well was determined in situ and expressed as number of doublings (NbD). Dose-response curves of the mean frequency of clones of each size versus log TPO concentration showed highly significant differences in the TPO concentration needed for half-maximum generation of clones of different sizes (TPO50): 1.89 +/- 0.51 pg/mL for 1 MK clones; 7.75 +/- 0.81 pg/mL for 2 to 3 MK clones; 38.5 +/- 5.04 pg/mL for 4 to 7 MK clones, and 91.8 +/- 16.0 pg/mL for 8 to 15 MK clones. These results were consistent with a prediction of the generation-age model, because the number of previous doublings in vivo was inversely correlated with the number of residual doublings in vitro. TPO responsiveness decreased in vitro by a factor of 3.5 per doubling, reflecting the recruitment of progressively more ancestral progenitors. In support of this hypothesis, the more mature CD34(+)CD41(+)CD42(+) cell fraction had a lower TPO50 (P <.001), underwent fewer NbD (P <.001), and expressed a 2.8-fold greater median Mpl receptor density (P <.001) than the CD34(+)CD41(+)CD42(-) fraction. Progenitors that have completed their proliferative program have maximum factor responsiveness and are preferentially induced to terminal differentiation. (C) 2004 by The American Society of Hematology.
Disciplines :
Hematology
Author, co-author :
Paulus, Jean-Michel ; Université de Liège - ULiège -Belgium > Laboratory of Hematology, CHU du Sart Tilman, Liège
Debili, Najet; Institut National de la Santé et de la Recherche Médicale - (INSERM) U362 >
Larbret, Fréféric; Institut National de la Santé et de la Recherche Médicale - (INSERM) U362) > Institut Gustave Roussy, Villejuif, France
Levin, Jack; Univerity of California School of Medicine, San Francisco, USA > Department of Laboratory Medicine.
Vainchenker, William; Institut National de la Santé et de la Recherche Médicale - (INSERM) U362 > Institut Gustave Roussy, Villjuif, France
Language :
English
Title :
Thrombopoietin responsiveness reflects the number of doublings undergone by megakaryocyte progenitors
Publication date :
15 October 2004
Journal title :
Blood
ISSN :
0006-4971
eISSN :
1528-0020
Publisher :
American Society of Hematology, Washington, United States - District of Columbia
Volume :
104
Issue :
8
Pages :
2291-2298
Peer reviewed :
Peer Reviewed verified by ORBi
Name of the research project :
Thrombocytopoiesis;
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique INSERM - Institut National de la Santé et de la Recherche Médicale
Commentary :
Progenitors that have completed their proliferative program have maximum factor responsiveness and are preferentially induced to terminal differentiation.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Paulus JM, Prenant M, Deschamps JF, Henry-Amar M. Polyploid megakaryocytes develop randomly from a multicompartmental system of committed progenitors. Proc Natl Acad Sci USA. 1982;79:4410-4414.
Paulus JM, Levin J, Debili N, Albert A, Vainchenker W. Genesis of clone size heterogeneity in megakaryocytic and other hemopoietic colonies. The stochastic model revisited. Exp Hematol. 2001:29:1256-1269.
Orkin SH. Transcription factors regulating early hematopoietic development and lineage commitment. In: Monroe JG, Rothenberg EV, eds. Molecular biology of B-cell and T-cell development. Totowa, NJ: Humana Press; 1999:41-54.
Matsumura I, Ishikawa J, Nakajima K, et al. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21WAF1/Cipl by STATS. Mol Cell Biol. 1997;17:2933-2943.
Nagata Y, Muro Y, Toobkoro K. Thrombopoietin-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis. J Cell Biol. 1997:139:449-457.
Vitrat M, Cohen-Solal K, Pique C, et al. Endomitosis of human megakaryocytes are due to abortive mitosis. Blood. 1998:91:3711-3723.
Huang C, Ferrell J Jr. Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA. 1996:93:10078-10083.
Ferrell JE, Machleder EM. The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science. 1998;280:895-898.
Matsumura I, Nakajima K, Wakao H, et al. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line. Mol Cell Biol. 1998:18:4282-4290.
Rojnuckarin P, Drachmen JG, Kaushansky K. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis. Blood. 1999;94:1273-1282.
Fichelson S, Freyssinier JM, Picard F, et al. Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors. Blood. 1999;94:1601-1613.
Levin J, Levin FC, Penington DG, Metcalf D. Measurement of ploidy distribution in megakaryocyte colonies obtained from culture: with studies of the effects of thrombocytopenia. Blood. 1981;57:287-297.
Metcalf D. Clonal analysis of proliferation and differentiation of paired daughter cells: action of granulocyte-macrophage colony-stimulating factor on granulocyte-macrophage precursors. Proc Natl Acad Sci U S A. 1980:77:5327-5330.
Bruno E, Huffman R. Human megakaryocyte progenitor cells. Semin Hematol. 1998;35:183-191.
Francis GE, Berney JJ, Bodger MP, et al. Clone size potential and sensitivity to colony-stimulating activity: differentiation-linked properties of granulocyte-macrophage progenitor cells. Stem Cells. 1981:1:124-139.
Eaves CJ, Eaves AC. Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera. Blood. 1978;52:1196-1210.
Long MW, Heffner CH, Gragowski LL. In vitro differences in responsiveness of early (BFU-Mk) and late (CFU-Mk) murine megakaryocyte progenitor cells. Prog Clin Biol Res. 1986;215:179-186.
Mintem J, Williams N, Jackson H. The relative population sizes of megakaryocytic cells in mouse bone marrow as determined by mpl ligand responsiveness. Exp Hematol. 1997:25:1233-1239.
Leary AG, Strauss LC, Civin CI, Ogawa M. Disparate differentiation in hemopoietic colonies derived from human paired progenitors. Blood. 1985:66:327-332.
Huang S, Law P, Francis K, Palsson BO, Ho AD. Symmetry of initial cell divisions among primitive hematopoietic progenitor is independent of ontogenic age and regulatory molecules. Blood. 1999;94:2595-2604.
Punzel M, Liu D, Zhang T, et al. The symmetry of initial divisions of human hematopoietic progenitors is altered only by the cellular microenvironment. Exp Hematol. 2003:31:339-347.
Takano H, Ema H, Sudo K, Nakauchi H. Asymmetric division and lineage commitment at the level of hematopoietic stem cells: inference from differentiation in daughter cell and granddaughter cell pairs. J Exp Med. 2004:199:295-302.
Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 1999;401:556-562.
Kondo M, Scherer DC, Miyamoto T, et al. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature. 2000:407:383-386.
Stellacci E, Testa U, Petrucci E, et al. Interferon regulatory factor-2 drives megakaryocytic differentiation. Biochem J. 2004:377:367-378.
Debili N, Coulombel L, Croisille L, et al. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood. 1996;88:1284-1296.
Debili N, Wendling F, Katz A, et al. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood. 1995;86:2516-2525.
Debili N, Robin C, Schiavon V, et al. Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates. Blood. 2001:97:2023-2030.
Kato T, Horie K, Hagiwara T, et al. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin. Exp Hematol. 1996;24:1209-1214.
Debili N, Wendling F, Cosman D, et al. The MpI receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood. 1995:85:391-401.
Debili N, Issaad C, Massé JM, et al. Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood. 1992;80:3022-3035.
den Dekker E, van Abel M, van der Vuurst H, van Eys GJ, Akkerman JW, Heemskerk JW. Cell-to-cell variability in the differentiation program of human megakaryocytes. Biochim Biophys Acta. 2003:1643:85-94.
Deveaux S, Filipe A, Lemarchandel V, et al. Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. Blood. 1996:87:4678-4685.
Hashimoto Y, Ware J. Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene. J Biol Chem. 1995:270:24532-24539.
Aitchison J, Brown J. The lognormal distribution with special reference to its use in economics. Cambridge, United Kingdom: Cambridge University Press: 1957.
Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995:80:179-185.
Dikic I, Schlessinger J, Lax I. PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation. Curr Biol. 1994;4:702-708.
Gao FB, Apperly J, Raff M. Cell-intrinsic timers and thyroid hormone regulate the probability of cell-cycle withdrawal and differentiation of oligodendrocyte precursor cells. Dev Biol. 1998:197:54-66.
Metcalf D, MacDonald HR. Heterogeneity of in vitro colony- and cluster-forming cells in the mouse marrow: segregation by velocity sedimentation. J Cell Physiol. 1975:85:643-654.
Labbaye C, Quarante MT, Pagliuca A, et al. PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein. Oncogene. 2002:21:6669-6679.
Correa PN, Axelrad AA. Production of erythropoietic bursts by progenitor cells from adult human peripheral blood in an improved serum-free medium: role of insulinlike growth factor 1. Blood. 1991:78:2823-2833.
Koury MJ. Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol. 1992;20:391-394.
Kelley LL, Koury MJ, Bondurant MC, et al. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood. 1993:82:2340-2352.
Majka M, Janowska-Wieczorek A, Ratajczak J, et al. Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis. Blood. 2000;96:4142-4151.
Pestina TI, Cleveland JL, Yang CY, Zambetti GP, Jackson CW. MpI ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis. Blood. 2001;98:2084-2090.
Millot GA, Vainchenker W, Dumenil D, Svinarchuk F. Distinct effects of thrombopoietin depending on a threshold level of activated MpI in BaF-3 cells. J Cell Sci. 2002:115:2329-2337.
Kirito K, Watanabe T, Sawada K, et al. Thrombopoietin regulates Bcl-xL gene expression through Stats and phosphatidylinositol 3-kinase activation pathways. J Biol Chem. 2002;277:8329-8337.
Tanaka R, Katayama N, Ohishi K, et al. Accelerated cell-cycling of hematopoietic progenitor cells by growth factors. Blood. 1995:86:73-79.
Muta K, Krantz SB, Bondurant MC, Dai CH. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood. 1995:86:572-580.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
